Influential CEO Jamie Dimon to Deliver Keynote at BIO 2019

April 30, 2019 Off By BusinessWire

JPMorgan Chase & Co. Chairman and CEO will talk leadership,
risk-taking and healthcare

WASHINGTON–(BUSINESS WIRE)–The Biotechnology Innovation Organization (BIO) today announced that
Chairman and CEO of JPMorgan Chase & Co., Jamie Dimon – a leader in the
banking industry and catalyst for innovation across American business,
including the healthcare industry – will headline a keynote address at
the 2019 BIO International Convention, the world’s premier life sciences
event being held in Philadelphia, June 3-6.

Dimon leads one of the oldest financial institutions in the U.S., with a
history dating back over 200 years, a presence in over 100 markets, and
over 250,000 employees. The firm has assets of $2.7 trillion and serves
millions of customers in the U.S. and many of the world’s most prominent
corporate, institutional and government clients. At the helm, Dimon has
led the launch of novel strategies to address diversity and healthcare
challenges, including Advancing Black Leaders and Women on the
Move
initiatives, and a recent partnership with Amazon and Berkshire
Hathaway to launch Haven, an independent company designed to address
healthcare for their U.S. employees and reduce associated costs. His
company has also launched AdvancingCities, a new $500 million,
five-year initiative to drive inclusive growth and create greater
economic opportunity in cities across the world.

“We are inspired by Jamie’s successful leadership of the world’s largest
banking institution and look forward to his views on ways in which
small, innovative companies can position themselves in the global
economy,” said Jim Greenwood, President and Chief Executive Officer of
BIO. “His innovative strategies for improving employee satisfaction, and
commitment to cultivating a new generation of diverse leadership are an
inspiration to the biotech community as we work to take actionable steps
toward a more diversified and inclusive industry.”

Dimon will address attendees on Wednesday, June 5, 2019 at the keynote
session from 9:00-10:30AM (EDT). The session is sponsored by Alnylam
Pharmaceuticals and is open to attendees with Convention Access or
higher.

BIO 2019 is expected to attract over 16,000 attendees and 1,800
exhibitors from 67 countries. Complimentary media
registration
is available to editors and reporters working full time
for print, broadcast or web publications with valid press credentials.

About Jamie Dimon

Named four times to Time Magazines TIME 100 most
influential people in the world list and Fortune’s World’s
Greatest Leaders for 2018 list, James Dimon became Chairman of the Board
of JPMorgan Chase & Co. (NYSE: JPM) in 2006, and has been Chief
Executive Officer and President since December 31, 2005. He was
President and Chief Operating Officer following JPMorgan Chase’s merger
with Bank One Corporation in July 2004. At Bank One, he was Chairman and
Chief Executive Officer from March 2000 to July 2004. Before joining
Bank One, Mr. Dimon held a wide range of executive roles at Citigroup
Inc., the Travelers Group, Commercial Credit Company and American
Express Company. He is on the Board of Directors of Harvard Business
School and Catalyst; Board of Trustees of New York University School of
Medicine Chairman of the Business Roundtable; and a member of The
Business Council. He has served on the board of directors of the Federal
Reserve Bank of New York and does not serve on the board of any publicly
traded company other than JPMorgan Chase. Mr. Dimon graduated from Tufts
University and received an M.B.A. from Harvard Business School.

About BIO

BIO is the world’s largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention
, the world’s largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW is
BIO’s blog chronicling “innovations transforming our world” and the BIO
Newsletter is the organization’s bi-weekly email newsletter. Subscribe
to the BIO Newsletter
.

Contacts

Theresa Brady
202.962.9235
Web:
www.bio.org
Blog:
www.biotech-now.org
Twitter:
@IAmBiotech